Author response for "Efficacy and safety of polyethylene glycol loxenatide ( <scp>PEX168</scp> ) monotherapy in type 2 diabetes patients: a multicenter, randomized, double‐blind, placebo‐controlled, phase 3a clinical trial"
semanticscholar（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要